Avinger achieves commercial milestone with more than 100 accounts using pantheris sv

Redwood city, ca / accesswire / april 15, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today reported that more than 100 accounts have purchased pantheris sv oct-guided atherectomy catheters for the treatment of pad since product launch in the third quarter of 2019. "by combining real-time intravascular imaging with the precise control of directional atherectomy, our pantheris sv device is proving to be an optimal choice for the treatment of peripheral artery disease in small vessels," commented jeff soinski, avinger's president and ceo.
AVGR Ratings Summary
AVGR Quant Ranking